Intraoperative Mass Spectrometry of Tumor Metabolites

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2014 Jul 17

PMID 25028494

Authors

Whitney B Pope

Affiliations

Soon will be listed here.

References

Cairns R, Mak T . Oncogenic isocitrate dehydrogenase mutations: mechanisms, models, and clinical opportunities. Cancer Discov. 2013; 3(7):730-41. DOI: 10.1158/2159-8290.CD-13-0083. View

Liu X, Ide J, Norton I, Marchionni M, Ebling M, Wang L . Molecular imaging of drug transit through the blood-brain barrier with MALDI mass spectrometry imaging. Sci Rep. 2013; 3:2859. PMC: 3790202. DOI: 10.1038/srep02859. View

Mrugala M . Advances and challenges in the treatment of glioblastoma: a clinician's perspective. Discov Med. 2013; 15(83):221-30. View

Tran D, Jensen R . Treatment-related brain tumor imaging changes: So-called "pseudoprogression" vs. tumor progression: Review and future research opportunities. Surg Neurol Int. 2013; 4(Suppl 3):S129-35. PMC: 3654777. DOI: 10.4103/2152-7806.110661. View

Sanai N, Berger M . Glioma extent of resection and its impact on patient outcome. Neurosurgery. 2008; 62(4):753-64. DOI: 10.1227/01.neu.0000318159.21731.cf. View

Beiko J, Suki D, Hess K, Fox B, Cheung V, Cabral M . IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection. Neuro Oncol. 2013; 16(1):81-91. PMC: 3870823. DOI: 10.1093/neuonc/not159. View

Santagata S, Eberlin L, Norton I, Calligaris D, Feldman D, Ide J . Intraoperative mass spectrometry mapping of an onco-metabolite to guide brain tumor surgery. Proc Natl Acad Sci U S A. 2014; 111(30):11121-6. PMC: 4121790. DOI: 10.1073/pnas.1404724111. View

Fabrizi G, Fioretti M, Mainero Rocca L, Curini R . DESI-MS2: a rapid and innovative method for trace analysis of six cytostatic drugs in health care setting. Anal Bioanal Chem. 2011; 403(4):973-83. DOI: 10.1007/s00216-011-5626-7. View

Eyupoglu I, Buchfelder M, Savaskan N . Surgical resection of malignant gliomas-role in optimizing patient outcome. Nat Rev Neurol. 2013; 9(3):141-51. DOI: 10.1038/nrneurol.2012.279. View

10.

Eberlin L, Liu X, Ferreira C, Santagata S, Agar N, Cooks R . Desorption electrospray ionization then MALDI mass spectrometry imaging of lipid and protein distributions in single tissue sections. Anal Chem. 2011; 83(22):8366-71. PMC: 3229813. DOI: 10.1021/ac202016x. View

11.

Eberlin L, Norton I, Orringer D, Dunn I, Liu X, Ide J . Ambient mass spectrometry for the intraoperative molecular diagnosis of human brain tumors. Proc Natl Acad Sci U S A. 2013; 110(5):1611-6. PMC: 3562800. DOI: 10.1073/pnas.1215687110. View

12.

Eberlin L, Tibshirani R, Zhang J, Longacre T, Berry G, Bingham D . Molecular assessment of surgical-resection margins of gastric cancer by mass-spectrometric imaging. Proc Natl Acad Sci U S A. 2014; 111(7):2436-41. PMC: 3932851. DOI: 10.1073/pnas.1400274111. View

13.

Eberlin L, Norton I, Dill A, Golby A, Ligon K, Santagata S . Classifying human brain tumors by lipid imaging with mass spectrometry. Cancer Res. 2011; 72(3):645-54. PMC: 3271168. DOI: 10.1158/0008-5472.CAN-11-2465. View

14.

Takats Z, Wiseman J, Gologan B, Cooks R . Mass spectrometry sampling under ambient conditions with desorption electrospray ionization. Science. 2004; 306(5695):471-3. DOI: 10.1126/science.1104404. View

15.

Stupp R, Mason W, van den Bent M, Weller M, Fisher B, Taphoorn M . Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005; 352(10):987-96. DOI: 10.1056/NEJMoa043330. View

16.

Agar N, Golby A, Ligon K, Norton I, Mohan V, Wiseman J . Development of stereotactic mass spectrometry for brain tumor surgery. Neurosurgery. 2010; 68(2):280-89. PMC: 3678259. DOI: 10.1227/NEU.0b013e3181ff9cbb. View